Weiss Multi-Strategy Advisers LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$97,000
-59.6%
30,000
-34.1%
0.00%
-60.0%
Q1 2016$240,000
-32.8%
45,5000.0%0.01%
-60.0%
Q4 2015$357,000
-24.0%
45,500
-18.3%
0.02%
+19.0%
Q3 2015$470,000
+97.5%
55,700
+178.5%
0.02%
+320.0%
Q1 2014$238,000
-17.1%
20,000
-3.6%
0.01%
-16.7%
Q4 2013$287,000
-58.9%
20,749
-48.1%
0.01%
-25.0%
Q3 2013$698,000
+330.9%
40,000
+300.0%
0.01%
+60.0%
Q2 2013$162,00010,0000.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders